Skip to main content
. 2023 May 22;8(7):652–661. doi: 10.1001/jamacardio.2023.1266

Figure 3. Patient-Level and Hospital-Level Characteristics Independently Associated With Discharge Use of Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Therapy.

Figure 3.

Forest plot depicting adjusted odds ratios (ORs) for SGLT2i prescription for patient and hospital characteristics included in the multivariable logistic regression model after backward variable selection. A P value threshold of .20 was used for backward variable selection. Kidney insufficiency was defined as chronic serum creatinine elevation greater than 2.0 mg/dL (to convert to micromoles per liter, multiply by 88.4). BMI indicates body mass index (calculated as weight in kilograms divided by height in meters squared); EF, ejection fraction; eGFR, estimated glomerular filtration rate; HMO; health maintenance organization; ICD, implantable cardioverter-defibrillator; TIA, transient ischemic attack.